Please login to the form below
commercialisation
This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.
Novartis and Precision BioSciences announce in vivo gene editing collaboration
Novartis will have an exclusive licence for further development of the custom ARCUS nuclease, taking charge of all subsequent research, development, manufacturing and commercialisation.
Latest news
-
Almirall shares positive topline results from atopic dermatitis trials
AD). While Almirall holds the licence to develop and commercialise lebrikizumab for the treatment of dermatology indications – including AD – in Europe, Eli Lilly retains the exclusive rights for development and commercialisation
-
Shionogi and F2G partner to develop antifungal treatment olorofim
According to the terms of the deal, Shionogi will conduct the clinical trials and subsequent registration and commercialisation of olorofim for IA in Europe and Asia.
-
Cancer Research UK drives innovation with Cancer Research Horizons
partners. Additionally, Horizons will provide intellectual property advice, research commercialisation support and an entrepreneurial programme and £30m of seed funding to help tackle the translational gap.
-
AbbVie ends partnership with BioArctic to develop treatment for Parkinson's disease
When the two companies began their research contract in 2016, AbbVie then had the right to acquire a licence for the development and commercialisation of BioArctic's portfolio of alpha-synuclein
-
Moderna appoints Jorge Gomez as chief financial officer
spring of 2020 to help us get Moderna ready for commercialisation in record time.
More from news
Approximately 0 fully matching, plus 563 partially matching documents found.
Latest Intelligence
-
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
The lines between healthcare, drug discovery, clinical research and commercialisation are blurring, as the patient becomes a key partner and focus.
-
Piloting a route to the biosimilars opportunities in Europe
The life sciences sector needs governments to introduce attractive policies and incentives that will encourage manufacturers to invest in development and commercialisation of biosimilars, to ensure competitive and sustainable supply and
-
Strategy experts: the real thing
Experts can exist in any part of our industry’s value chain, from discovery to commercialisation and all points in between.
-
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
Along with securing investment, they also need to improve the overall implementation of commercialisation.
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
These partners can help assess the commercial opportunity of external products or portfolios and determine how well they fit with a company’s resources, research focus, and commercialisation strategies.
More from intelligence
Approximately 2 fully matching, plus 134 partially matching documents found.
Latest appointments
-
Ashfield appoints new UK head of patient solutions
Stephanie Hill strengthens the commercial team at leading healthcare network. Ashfield, a leader in commercialisation services for the healthcare industry, has appointed Stephanie Hill (pictured above) as its new head of
-
Health comms agency emotive hires new cell and gene therapy leader
Dr Germano Ferrari. His most recent role was as a programme manager at the UK’s Cell and Gene Therapy Catapult where he helped develop commercialisation pathways for several pre-clinical
-
New hires at Ferring, Flexion and Immunocore
Berman initially joined the biotech back in September last year with the aim to advance the company’s lead candidate IMCgp100 towards commercialisation. ... IMCgp100, towards commercialisation.”.
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Her appointment will significantly strengthen Immunocore as we advance our lead candidate, IMCgp100, towards commercialisation, and our growing pipeline of TCR candidates through clinical development.”.
-
BMS appoints new commercial leader, Davies joins Eisai and more
His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries.
More from appointments
Approximately 0 fully matching, plus 122 partially matching documents found.
Latest from PMHub
-
Reflections on the MAPS EMEA 2022 Annual Meeting
Nucleus X Consulting consists of a group of specialist practices, with deep expertise in patient engagement, rare disease, and early-phase medical commercialisation. ... We partner with our clients to drive successful drug commercialisation, leveraging
-
Nucleus X Consulting – where patient engagement meets strategic consultancy
With accelerated time to commercialisation, early preparation and a tailored launch strategy are essential. ... About Nucleus X Consulting and Nucleus Global. Nucleus X Consulting consists of a group of specialist practices, with deep expertise in
-
Rare Disease Day – looking to the future with hope
Collaboration. Progress would not be possible without collaboration at all stages in the commercialisation of rare disease drugs, from clinical development to product launch, to those working hard to elevate the ... However, challenges in the
-
PulmoBioMed Wins National Life Science Competition
PulmoBioMed is a newly launched Northumbria University spinout, founded by Associate Professor Dr Sterghios Moschos and supported into commercialisation by Chief Executive Officer Dr Pete Hotten, who has over 20 years
-
How a design mindset can lead to better medical outcomes
a set sequence that risked excluding patient understanding and insight, pre-commercialisation. ... The insight can help build an educational programme that works in part as a pre-commercialisation process.
More from PMHub
Approximately 5 fully matching, plus 40 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- Gilead Sciences supports Kigali Declaration for neglected tropical diseases
- As the NHS turns 74, it launches its ‘biggest NHS Big Tea ever’ to raise funds
- FDA issues innovative proposal to increase nonprescription drug access
- European Commission approves potential new treatment for Pompe disease
- Connect to the conversation around mental health: A spotlight on physician burnout
- How understanding the rare disease patient’s lived experience creates better health communications
- A creative awakening – how pharma is bringing innovation to the patient journey
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- European Commission approves potential new treatment for Pompe disease
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- FDA issues innovative proposal to increase nonprescription drug access
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
PMHub
Spirit, an OPEN Health Company
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...
Latest intelligence
- Virtual MSL/Sales training programs and events
- Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
- Omnichannel strategies to revolutionize the healthcare professional experience
- Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...
